The effect of gliquidone on KATP channels in pancreatic β-cells, cardiomyocytes, and vascular smooth muscle cells.

作者: Shu-Yi Liu , Hao-Min Tian , Da-Qing Liao , Yan-Fang Chen , Zhong-Ping Gou

DOI: 10.1016/J.DIABRES.2015.05.036

关键词: GlibenclamideEndocrinologyGliquidonePatch clampSecretagogueGliclazideMedicineATP-sensitive potassium channelSulfonylurea receptorInternal medicineVascular smooth muscle

摘要: Abstract Aims Sulfonylurea drugs exert an insulinotropic effect through ATP-sensitive potassium (K ATP ) channel inhibition in pancreatic islet cells. These channels are also expressed cardiomyocytes and vascular smooth muscle cells (VSMCs), suggesting potential for adverse cardiovascular effects. We evaluated the effects of Gliquidone (Glq) on sulfonylurea receptors HIT-T15 (SUR1), (SUR2A), VSMCs (SUR2B). Methods The concentration-dependent Glq (0.001–500 μM) K were assessed using whole-cell patch clamp cells, rat cardiomyocytes, VSMCs. Parallel studies Glibenclamide (Glb) (0.001–10 μM) Gliclazide (Glc) (0.01–500 μM)were conducted as controls. Results In HIT–T15 Glb exhibited lowest IC 50 (0.03 μM), compared to (0.45 μM) Glc (1.21 μM). However, had higher cardiomyoctes VSMCs, (119.1 vs. 0.01 149.7 vs . 0.09 μM, respectively), that is more selective β-cells than Glb. Thus, may have fewer side Conclusions a highly SUR secretagogue with moderate affinity β-cells, but low Our data reveal non-selective nature Glb, evidenced by high binding all three cell types examined.

参考文章(19)
Zhao-Yang Hu, Peng-Tao Lin, Jin Liu, Da-Qing Liao, None, Remifentanil induces L-type Ca2+ channel inhibition in human mesenteric arterial smooth muscle cells. Canadian Journal of Anaesthesia-journal Canadien D Anesthesie. ,vol. 55, pp. 238- 244 ,(2008) , 10.1007/BF03021508
R. Mitra, M. Morad, A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates American Journal of Physiology-heart and Circulatory Physiology. ,vol. 249, ,(1985) , 10.1152/AJPHEART.1985.249.5.H1056
Hanna Eskinder, Debebe Gebremedhin, Joseph G. Lee, Nancy J. Rusch, Franjo D. Supan, John P. Kampine, Zeljko J. Bosnjak, Halothane and isoflurane decrease the open state probability of K+ channels in dog cerebral arterial muscle cells. Anesthesiology. ,vol. 82, pp. 479- 490 ,(1995) , 10.1097/00000542-199502000-00018
Frances M. Ashcroft, Patrik Rorsman, Electrophysiology of the pancreatic beta-cell. Progress in Biophysics & Molecular Biology. ,vol. 54, pp. 87- 143 ,(1989) , 10.1016/0079-6107(89)90013-8
Thomas P. Flagg, Decha Enkvetchakul, Joseph C. Koster, Colin G. Nichols, Muscle KATP Channels: Recent Insights to Energy Sensing and Myoprotection Physiological Reviews. ,vol. 90, pp. 799- 829 ,(2010) , 10.1152/PHYSREV.00027.2009
Toshiaki Sato, Hirofumi Nishida, Masaru Miyazaki, Haruaki Nakaya, Effects of sulfonylureas on mitochondrial ATP-sensitive K+ channels in cardiac myocytes: implications for sulfonylurea controversy. Diabetes-metabolism Research and Reviews. ,vol. 22, pp. 341- 347 ,(2006) , 10.1002/DMRR.621
F Tomai, F Crea, A Gaspardone, F Versaci, R De Paulis, A Penta de Peppo, L Chiariello, P A Gioffrè, Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation. ,vol. 90, pp. 700- 705 ,(1994) , 10.1161/01.CIR.90.2.700
David M. Flynn, Andrew H. Smith, Judith L. Treadway, Carolyn B. Levy, Walter C. Soeller, Wayne A. Boettner, Peter Wisniecki, David R. Plowchalk, Steve S. Gernhardt, W. Ross Tracey, Delvin R. Knight, The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbits. Cardiovascular Drugs and Therapy. ,vol. 19, pp. 337- 346 ,(2005) , 10.1007/S10557-005-4970-2
F. M. Gribble, F. M. Ashcroft, Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide. Diabetologia. ,vol. 42, pp. 845- 848 ,(1999) , 10.1007/S001250051236
M. Angelyn Bethel, Harald Sourij, Impact of FDA Guidance for Developing Diabetes Drugs on Trial Design: From Policy to Practice Current Cardiology Reports. ,vol. 14, pp. 59- 69 ,(2012) , 10.1007/S11886-011-0229-7